|
Merck's medicine bag helps asthmatics breathe easier and allows hypertension patients to relax a little. In addition to blockbuster asthma treatment Singulair, the pharmaceutical company's top sellers include cardiovascular drugs ranging from hypertension fighters Cozaar and Hyzaar to cholesterol combatants Vytorin, Zetia, and Zocor. Merck makes drugs in a broad range of other therapeutic areas as well: Januvia is a therapy for type 2 diabetes, Fosamax fights osteoporosis, and Cosopt and Trusopt treat eye disease. In addition to pharmaceuticals, the company makes childhood and adult vaccines for such diseases as measles, mumps, hepatitis, and shingles. Merck has agreed to acquire Schering-Plough for $41 billion.
|
| | | Contact Information | |
Address: |
1 Merck Dr.
Whitehouse Station, NJ 08889-0100
| | Phone: | 908-423-1000 | | Fax: | 908-735-1253 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 23850.30 M | | Revenue Growth (1 yr): | (-1.40%) | | Employees (2008): | 55,200 | | Employee Growth (1 yr): | (-7.70%) |
|
|
Key People
| | • |
Chairman, President, and CEO:
Richard T. (Dick) Clark
| | • |
EVP and CFO:
Peter N. Kellogg
| | • |
EVP Global Services and CIO:
J. Chris Scalet
|
|
|
